[
    "{\"step_by_step_thinking\": \"According to the relevant documents, Vedolizumab concentrations have been detected in the breast milk of nursing mothers with inflammatory bowel disease. Document [0] states that Vedolizumab was detectable in ~90% of milk samples collected from all patients. Document [1] also confirms the presence of Vedolizumab in breast milk of lactating women who received Vedolizumab. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]